PAREXEL and Meiji Pharmaceutical University Announce Academic Program
PAREXEL International Corporation and Meiji Pharmaceutical University announced a new Joint Program for Clinical Research and Clinical Trial Management for undergraduate students. The program offers students an accredited, four-week course designed to prepare them for careers in the biopharmaceutical industry which will be provided through PAREXEL’s clinical research expertise and MPU’s industry training experience.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025